NSEDCP
MDGL icon

NJ State Employees Deferred Compensation Plan’s Madrigal Pharmaceuticals MDGL Stock Holding History

NJ State Employees Deferred Compensation Plan’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,500
Closed -$688K – 242
2025
Q3 		$688K Hold
1,500
– – 0.08% 244
2025
Q2 		$454K Hold
1,500
– – 0.05% 294
2025
Q1 		$497K Hold
1,500
– – 0.06% 268
2024
Q4 		$463K Hold
1,500
– – 0.06% 307
2024
Q3 		$318K Hold
1,500
– – 0.04% 363
2024
Q2 		$420K Hold
1,500
– – 0.05% 315
2024
Q1 		$401K Hold
1,500
– – 0.05% 327
2023
Q4 		$347K Hold
1,500
– – 0.05% 353
2023
Q3 		$219K Hold
1,500
– – 0.03% 412
2023
Q2 		$347K Hold
1,500
– – 0.05% 346
2023
Q1 		$363K Buy
+1,500
New +$409K 0.06% 343

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return